News Focus
News Focus
Followers 35
Posts 8860
Boards Moderated 1
Alias Born 04/04/2020

Re: Bouf post# 417673

Saturday, 11/04/2023 6:59:26 PM

Saturday, November 04, 2023 6:59:26 PM

Post# of 447410
Bouf, I understand your skepticism. The generic companies purchase API. They don't produce it. If Amarin can continue to open non US markets they should be able to establish a pricing advantage in the US. If a cheaper production method is discovered it wouldn't necessarily provide either side advantage.
Sleven,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News